Partial safety of the new COX-2 inhibitor rofecoxib in NSAIDs high sensitive patients

Authors

  • A. Matucci,

    1. Department of Internal Medicine
      Section of Immunoallergology and Respiratory Diseases
      University of Florence
      Policlinico di Careggi
      Viale Morgagni 85
      50134 Florence
      Italy
      Tel: +39 055 4296426
      Fax: +39 055 412867
      E-mail: a.matucci@dmi.unifi.it
    Search for more papers by this author
  • P. Parronchi,

    1. Department of Internal Medicine
      Section of Immunoallergology and Respiratory Diseases
      University of Florence
      Policlinico di Careggi
      Viale Morgagni 85
      50134 Florence
      Italy
      Tel: +39 055 4296426
      Fax: +39 055 412867
      E-mail: a.matucci@dmi.unifi.it
    Search for more papers by this author
  • A. Vultaggio,

    1. Department of Internal Medicine
      Section of Immunoallergology and Respiratory Diseases
      University of Florence
      Policlinico di Careggi
      Viale Morgagni 85
      50134 Florence
      Italy
      Tel: +39 055 4296426
      Fax: +39 055 412867
      E-mail: a.matucci@dmi.unifi.it
    Search for more papers by this author
  • O. Rossi,

    1. Department of Internal Medicine
      Section of Immunoallergology and Respiratory Diseases
      University of Florence
      Policlinico di Careggi
      Viale Morgagni 85
      50134 Florence
      Italy
      Tel: +39 055 4296426
      Fax: +39 055 412867
      E-mail: a.matucci@dmi.unifi.it
    Search for more papers by this author
  • F. Brugnolo,

    1. Department of Internal Medicine
      Section of Immunoallergology and Respiratory Diseases
      University of Florence
      Policlinico di Careggi
      Viale Morgagni 85
      50134 Florence
      Italy
      Tel: +39 055 4296426
      Fax: +39 055 412867
      E-mail: a.matucci@dmi.unifi.it
    Search for more papers by this author
  • E. Maggi,

    1. Department of Internal Medicine
      Section of Immunoallergology and Respiratory Diseases
      University of Florence
      Policlinico di Careggi
      Viale Morgagni 85
      50134 Florence
      Italy
      Tel: +39 055 4296426
      Fax: +39 055 412867
      E-mail: a.matucci@dmi.unifi.it
    Search for more papers by this author
  • S. Romagnani

    1. Department of Internal Medicine
      Section of Immunoallergology and Respiratory Diseases
      University of Florence
      Policlinico di Careggi
      Viale Morgagni 85
      50134 Florence
      Italy
      Tel: +39 055 4296426
      Fax: +39 055 412867
      E-mail: a.matucci@dmi.unifi.it
    Search for more papers by this author

  • COX-2 inhibitor is relatively safe in patients with a high degree of NSAIDs hypersensitivity.

No abstract is available for this article.

Ancillary